PRODUCT LITERATURE

Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children (Review)

---

There are several treatment options for managing acute asthma exacerbations (sustained worsening of symptoms that do not subside
with regular treatment and require a change in management). Guidelines advocate the use of inhaled short acting beta2-agonists (SABAs)
in children experiencing an asthma exacerbation. Anticholinergic agents, such as ipratropium bromide and atropine sulfate, have a
slower onset of action and weaker bronchodilating effect, but may specifically relieve cholinergic bronchomotor tone and decrease
mucosal edema

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Respivent

Specific Detail Info

The Cochrane Library 2013, Issue 9

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment